Please join us next Tuesday, October 1... - Lung Cancer Support

Lung Cancer Support

4,066 members2,214 posts

Please join us next Tuesday, October 15th, for our Living Room discussion on Treating EGFR Mutated Non-Small Cell Lung Cancer

Michelezeh profile image
MichelezehAdministrator
0 Replies

Hello,

Please join us in our San Carlos office next Tuesday October 15th in person or if you don’t live in the area, you can join us virtually on GO2's YouTube Live channel.

We are thrilled to have Dr. Shane Dormady, MD, Hematology & Oncology, El Camino Hospital Cancer Center he will be discussing Treating EGFR Mutated NSCLC.

Join us for a conversation on how new targeted therapies and a greater understanding of tumor biology have advanced treatments for EGFR-mutated non-small cell lung cancer (NSCLC). First-generation targeted therapy drugs outperformed traditional chemotherapy, but new mutations led to resistance. Researchers developed second and third-generation drugs to combat these resistant mutations. They are also combining treatments (like immunotherapy and chemotherapy) and testing new drugs to improve patient outcomes.

If joining in person you can arrive at 5:00pm PST to mingle, grab some food, find a seat and get comfy with our program starting at 5:30pm PST to 6:30pm PST. Our address is 1100 Industrial Road. Suite 1 San Carlos CA. 94070.

If joining online, please click on the YouTube link at 5:30pm PST/8:30pm EST Click here: youtube.com/go2foundationfo... will not show running until start time.

We can't wait to see you all in person or online.

Big Hugs,

Michele

Written by
Michelezeh profile image
Michelezeh
Administrator
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...
Miranda_GO2 profile image
Partner

Opdivo and Yervoy combination approved for Non-small cell lung cancer

More exciting approval announcements for this week. On May 15th, 2020, the Food and Drug...
Miranda_GO2 profile image
Partner

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
Miranda_GO2 profile image
Partner

Merry-Go-Round

I feel like this merry-go-round never lets me off. In1993, I was a Care-giver for my husband who...
Ncpoet profile image

I'm Over in the Infusion Room, With Everyone Else

Since I last wrote a blog post for this site, I’ve enrolled in and left a clinical trial, taken a...
scifiknitter profile image
Blogger

Moderation team

See all
AmyKamp profile image
AmyKampAdministrator
SarahMcHale profile image
SarahMcHaleAdministrator
Maureen-GO2 profile image
Maureen-GO2Administrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.